Doctors News Hubb
Advertisement Banner
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us
No Result
View All Result
Doctors News Hubb
No Result
View All Result
Home News

Smartphone-based self-management intervention may decrease relapses for patients with Bipolar Disorder Type 1

admin by admin
January 1, 2023
in News


1. In patients with Bipolar Disorder Type 1, a smartphone-based self-management intervention decreased relapse risk in individuals in asymptomatic recovery but not in those with a higher relapse risk.

Evidence Rating Level: 1 (Excellent) 

Bipolar disorder, characterized by episodes of mania and depression, is a severe mental illness that causes significant disability even with appropriate pharmacological therapy. While evidence suggests that dual treatment with psychotherapy and pharmacotherapy is ideal in improving relapse risk and symptom burden, access to this is limited. Smart phone-based interventions provide a means for individuals to access self-management strategies derived from present bipolar disorder psychotherapy; however, the exact effect of this is unknown. In this randomized controlled trial, 205 adults with an established diagnosis of bipolar disorder type 1 who were receiving mental health care from a psychiatrist, were randomized to either the intervention group or control group and stratified based on their risk of relapse. Individuals assigned to the smart phone intervention group used an app over a period of 16 weeks which provided adaptive feedback and information for developing a personalized wellness plan and additionally visited a coach for support. The primary outcomes of this study were time to relapse, and quality of life measured by the World Health Organization (WHO) Quality of Life (QOL) questionnaire. The results of this study showed that time to relapse was longer in the intervention group compared to the control group in the low-risk group (HR 0.32, 95%CI 0.47-1.57) than the high-risk group (HR 0.86, 95%CI 0.47-1.57). Additionally, there was no difference in quality-of-life scores between the two groups. In conclusion, this paper did not observe a difference in relapse of a mood episode amongst the smart phone-based self-management group. However, in individuals with a lower risk of relapse to begin with, the relapse risk was lower with the smartphone intervention. This study had several limitations that must be taken into consideration. A significant portion of the sample was Caucasian participants so the generalizability of these findings may be limited. Nevertheless, as this study does demonstrate some benefit of smartphone interventions in those at a lower risk for relapse, further research into this area may be beneficial. 

Click to read the study in JAMA Psychiatry

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 



Source link

Advertisement Banner
Previous Post

Envision Health-California lawsuit tackles private equity in medicine

Next Post

Hospital systems create in-house staffing teams to fuel shortages

Related Posts

News

Treatment of Older Adults’ Constipation Caused by Opioids

February 7, 2023
News

Serious Illness: Advance Care Planning

February 6, 2023
News

Dual antiplatelet therapy discontinued 9 months after percutaneous coronary intervention associated with improved morbidity and mortality

February 5, 2023
News

#VisualAbstract: Aldosterone synthase inhibition reduced systolic blood pressure in patients with treatment-resistant hypertension

February 4, 2023
News

Risk of Severe COVID-19 Infection and Other SARIs in Preexisting Neuropsychiatric Conditions

February 3, 2023
News

Vitiligo Responding and Refractory Alopecia Areata During the Monotherapy With Tofacitinib

February 2, 2023
Next Post

Hospital systems create in-house staffing teams to fuel shortages

Recommended

Blue Cross plans launch Synergie Medication Collective

1 month ago

Why Dental Suction Devices Are Necessary During Oral Surgery

4 weeks ago

What Should Be in a First Responder’s Tactical Trauma Kit?

3 months ago

Why Are Automated Boot Scrubbers Best for Food Safety?

2 months ago

Lessons learned from reporting on sex trafficking survivor stories

2 months ago

© 2022 Doctors News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us

© 2022 Doctors News Hubb All rights reserved.